Skip to main content

Published locations for Studies address ibrutinib bleeding risk in patients with CLL receiving Mohs surgery

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Studies address ibrutinib bleeding risk in patients with CLL receiving Mohs surgery

User login

  • Reset your password
  • /content/studies-address-ibrutinib-bleeding-risk-patients-cll-receiving-mohs-surgery
  • /edermatologynews/article/255085/dermatologic-surgery/studies-address-ibrutinib-bleeding-risk
  • /hematologynews/article/255085/dermatologic-surgery/studies-address-ibrutinib-bleeding-risk-patients
  • /oncologypractice/article/255085/dermatologic-surgery/studies-address-ibrutinib-bleeding-risk
  • /hematology-oncology/article/255085/dermatologic-surgery/studies-address-ibrutinib-bleeding-risk
  • /dermatology/article/255085/dermatologic-surgery/studies-address-ibrutinib-bleeding-risk-patients-cll
  • /surgery/article/255085/dermatologic-surgery/studies-address-ibrutinib-bleeding-risk-patients-cll
  • /b-cell-lymphoma-icymi/article/255085/dermatologic-surgery/studies-address-ibrutinib-bleeding-risk